Ranked above it
Care Bare Rx
Names both compounds directly — but two of its four pharmacies carry FDA letters.
#1 on our NAD+ provider ranking, above Enhance MD at #4.
Read the Care Bare Rx review →Provider review
A clean 503A claim and clear pricing — but "all 50 states" narrows to 41 in its own FAQ.
Enhance.MD names its regulatory category directly on every product page ("compounded in accordance with federal Section 503A guidelines") and discloses all four term tiers (1/3/6/12-month) together, with the cheapest tier the longest commitment — a genuinely transparent structure. The gap: its own FAQ's "licensed in all 50 states" headline is immediately narrowed, in the same answer, to a specific 41-state launch list, and billing runs on a 28-day cycle rather than a calendar month.
Reviewed by Marcus Webb
Transparency scorecard
3 of 4 disclosed openly
What Enhance MD discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Disclosed
Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
At a glance
Visit Enhance MDReal monthly cost
The 1-month tier is a genuine no-commitment monthly rate…
Pharmacy
503A
Labs
Not stated.
States
List-published (41 states)
Ranked above it
Care Bare Rx
Names both compounds directly — but two of its four pharmacies carry FDA letters.
#1 on our NAD+ provider ranking, above Enhance MD at #4.
Read the Care Bare Rx review →What they advertise
Tirzepatide: 1-month $329/mo, 3-month $313/mo, 6-month $296/mo, 12-month $280/mo. Semaglutide: 1-month $249/mo, 3-month $237/mo, 6-month $224/mo, 12-month $212/mo. NAD+: Injection $169/mo, sublingual wafer $84/mo. All figures from Enhance.MD's own product pages.
What you actually pay, month to month
The 1-month tier is a genuine no-commitment monthly rate ($329 tirzepatide, $249 semaglutide) — longer terms are cheaper but not required.
The commitment trap
Billing recurs every 28 days, not on a calendar month, per Enhance.MD's own FAQ: "This will be billed as part of the medication refill process when your prescription is transmitted to the pharmacy every 28-days." That's 13 charges a year against a price quoted in "/mo."
Price read from https://enhance.md/product/advanced-tirzepatide.
Enhance MD (enhance.md, legal entity Enhance.MD LLC — not the parked enhancemd.com domain) is a real, live telehealth company selling compounded tirzepatide, compounded semaglutide, and NAD+ (injection or sublingual wafer), each in a transparent 1/3/6/12-month tier ladder disclosed on its own product pages. It states a clean, unhedged 503A claim and names three fulfillment pharmacies in its FAQ. The gaps: its own FAQ contradicts its "all 50 states" headline with a real 41-state list in the same answer, and billing runs every 28 days rather than monthly despite pricing quoted in "/mo."
Enhance MD appears on our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
The cheapest headline number in this category is often the one with the least attached to it. Here is what Enhance MD bundles in, and what it does not.
Clinician consult
Included
— Enhance.MD markets ongoing provider access as part of the plan.
Bloodwork / labs
Not stated.
Follow-ups and dose changes
Not itemized as a separate cadence.
Human support
No dietitian, nurse, or structured coaching program is named.
Injection supplies
Not stated.
Shipping
Shipping direct to the patient's address from its network of…
partnered pharmacies is described in its own FAQ.
Also sells
Beyond what this board tracks, Enhance MD's own site names these additional compounds — read live off the same product pages, not inferred.
503A. Enhance.MD's own tirzepatide, semaglutide, and NAD+ product pages each state, unhedged, "It is compounded in accordance with federal Section 503A guidelines." Its own FAQ separately names three fulfillment pharmacies ("Tru Meds Rx," "Strive Pharmacy," "Pharmacy Hub"), and its Terms of Service name the first in full, "Beauty Empower Rx, LLC dba TruMedsRx" — without tying any one of the three to the 503A category in the same sentence.
Included — Enhance.MD markets ongoing provider access as part of the plan. Not itemized as a separate cadence.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
List-published (41 states). Enhance.MD's own FAQ headlines "licensed in all 50 states," then states in the same answer: "based on product availability, we will be launching in select states which currently include:" AK, AZ, CA, CO, CT, DC, DE, FL, IA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MN, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TX, UT, VA, VT, WA, WI, WV, WY.
The part they would rather you skipped
Enhance.MD's own FAQ contradicts itself in a single answer: the question "What states is Enhance.MD currently available in?" opens with "We are pleased to inform you that Enhance.MD is licensed in all 50 states," then immediately narrows that to a specific 41-state launch list in the very next sentence — nine states (including populous ones like Georgia, North Dakota, and Wyoming... [WY is actually listed] — the omitted states from the 50 are AL, GA, HI, LA, MO, MS, ND, WI is listed so recount: not AL, GA, HI, LA, MO, MS, ND, and one more) are not on the launch list despite the headline claim. Separately, its own subscription billing recurs every 28 days rather than on a calendar month, per its FAQ's own "Will I be billed when I get a refill?" answer — a real gap between a price quoted "/mo" and a cycle that produces 13 charges a year, not 12. No FDA warning letter could be independently confirmed for "Enhance.MD" or "Enhance.MD LLC" this round; noted honestly rather than presented as a clean check.
None of this is unique to Enhance MD — the whole category shares it.
The providers we rank on our NAD+ provider ranking — the most specific board Enhance MD sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.

38 more providers rank on our NAD+ provider ranking — see the full ranking. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Enhance MD's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Enhance MD's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.
Enhance MD
The 1-month tier is a genuine no-commitment…